Gynecologic laparoscopic surgery is not associated with an increase of serotonin metabolites excretion

Anesthesia and Analgesia

Volumn 87, Issue 5, 1998, Pages 1104-1108

  Borgeat, Alain ^a,c   Hasler, Patrick ^b   Fahti, Marc ^b  

^a BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CISPLATIN; SEROTONIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EXCRETION; DRUG RECEPTOR BINDING; FEMALE; GYNECOLOGIC SURGERY; HUMAN; LAPAROSCOPIC SURGERY; METABOLITE; NAUSEA; PNEUMOPERITONEUM; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SEROTONIN METABOLISM; SEROTONIN RELEASE; VOMITING;

ADULT; AGED; ANALGESICS, OPIOID; FEMALE; FENTANYL; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; HYDROXYINDOLEACETIC ACID; LARYNGOSCOPY; MIDDLE AGED; MORPHINE; POSTOPERATIVE NAUSEA AND VOMITING; SEROTONIN;

EID: 0031755358     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199811000-00022     Document Type: Article

References (31)

1. 3 receptor antagonist. Anesth Analg 1991;72:751-5.
2. McKenzie R, Kovac A, O'Connor T, et al. Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology 1993;78:21-8.
3. Khalil S, Kataria B, Pearson K, et al. Ondansetron prevents postoperative nausea and vomiting in women outpatients. Anesth Analg 1994;79:845-51.
4. Beattie WS, Lindblad T, Buckley DN, Forrest JB. The incidence of postoperative nausea and vomiting in women undergoing laparoscopy is influenced by the day of menstrual cycle. Can J Anaesth 1991;38:298-302.
5. Cunningham AJ, McCoy D. Anesthetic implications of laparoscopic surgery. Adv Anesth 1994;11:137-72.
6. Hindle AT. Recent developments in the physiology and pharmacology of 5-hydroxytryptamine. Br J Anaesth 1994;73: 395-407.
7. Buell MG, Harding RK. Proinflammatory effects of local abdominal irradiation on rat gastrointestinal tract. Dig Dis Sci 1989;34: 390-9.
8. Cubeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin induced nausea and vomiting. N Engl J Med 1990;322:810-6.
9. Du Bois A, Siebert C, Kriesinger-Schroeder H. Cisplatin-induced alterations of serotonin metabolism in patients with and without emesis. Oncol Rep 1995;2:839-42.
10. Shihabi ZK, Scaro J. Liquid-chromatographic assay of urinary 5-hydroxy-3-indoleacetic acid, with electrochemical detection. Clin Chem 1980;26:907-9.
11. Wilder-Smith OHG, Borgeat A, Chappuis P, et al. Urinary serotonin metabolite excretion during cisplatin chemotherapy. Cancer 1993;72:2239-41.
12. Miller AD, Nonaka S. Mechanisms of vomiting induced by serotonin-3 receptors agonists in the cat: effect of vagotomy, splanchnicectomy or area postrema lesion. J Pharmacol Exp Ther 1992;260:509-17.
13. Bertaccini G. Tissue 5-hydroxytryptamine and urinary 5-hydroxyindoleacetic acid after partial or total removal of the gastro-intestinal tract in the rat. J Physiol 1960;153:239-49.
14. Costall B, Naylor RJ. Neuropharmacology of emesis in relation to clinical response. Br J Cancer 1992;66(Suppl XIX):S2-8.
15. Leslie RA, Reynolds DJM, Andrews PLR, et al. Evidence for presynaptic 5-hydroxytryptamine recognition sites on vagal afferent terminals in the brainstem of the ferret. Neuroscience 1990;38:667-73.
16. Vermorken JB, Pinedo HM. Gastrointestinal toxicity of cis-diamminedichloroplatinum. Neth J Med 1982;25:270-4.
17. Higgins GA, Kilpatrick GJ, Bunce KT, et al. 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol 1989;97:247-55.
18. Andrews PLR, Davis CJ, Bingham S, et al. The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can J Physiol Pharmacol 1990;68:325-45.
19. Kalia M, Mesulam MM. Brain stem projections of sensory and motor components of the vagus complex in the cat. II. Laryngeal, tracheobronchial, pulmonary, cardiac, and gastrointestinal branches. J Comp Neurol 1980;193:467-508.
20. Milne RJ, Heel RC. Ondansetron: therapeutic use as an antiemetic. Drugs 1991;41:574-95.
21. Sniadach MS, Alberts MS. A comparison of the prophylactic antiemetic effect of ondansetron and droperidol on patients undergoing gynecologic laparoscopy. Anesth Analg 1997;85: 797-800.
22. Koivuranta MK, Läärä E, Ryhänen PT. Antiemetic efficacy of prophylactic ondansetron in laparoscopic cholecystectomy. Anaesthesia 1996;51:52-5.
23. Grunberg SM, Hesketh PJ. Control of chemotherapy-induced emesis. N Engl J Med 1993;329:1790-6.
24. Raphael JH, Norton AC. Antiemetic efficacy of prophylactic ondansetron in laparoscopic surgery: randomized, double-blind comparison with metoclopramide. Br J Anaesth 1993;71:845-8.
25. Sukhani R, Lurie J, Jabamoni R. Propofol for ambulatory gynecologic laparoscopy: does omission of nitrous oxide alter postoperative emetic sequelae and recovery? Anesth Analg 1994;78: 831-5.
26. Kamath B, Curran J, Hawkey C, et al. Anaesthesia, movement and emesis. Br J Anaesth 1990;64:728-30.
27. Muir JJ, Warner MA, Offord KP, et al. Role of nitrous oxide and other factors in postoperative nausea and vomiting: a randomized and blinded prospective study. Anesthesiology 1987;66: 513-8.
28. Purkis IE. Factors that influence postoperative vomiting. Can Anaesth Soc J 1964;11:335-53.
29. Kortilla K. The study of postoperative nausea and vomiting. Br J Anaesth 1992;69(Suppl 1):20S-3S.
30. Ramsay TM, McDonald PF, Faragher EB. The menstrual cycle and nausea or vomiting after wisdom teeth extraction. Can J Anaesth 1994;41:798-801.
31. Honkavaara P, Lehtinen AM, Hovorka J, Korttila K. Nausea and vomiting after gynaecological laparoscopy depends upon the phase of the menstrual cycle. Can J Anaesth 1991;39:876-9.